AI reads brain scans to spot tumors without a biopsy

NCT ID NCT07703761

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study explores whether artificial intelligence can analyze MRI scans to detect, map, and characterize gliomas—a common type of brain tumor—without needing an invasive biopsy. Researchers will collect existing MRI and clinical data from about 700 patients across Italy to train AI models. The goal is to help doctors make faster, more accurate treatment decisions and potentially reduce the need for surgical tissue sampling.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-driven analysis of brain MRI data using convolutional neural networks, recurrent neural networks, and vision transformers
What this could lead to
If successful, this could lead to faster, non-invasive diagnosis of brain tumors and more personalized treatment planning, reducing the need for biopsies.
What could go wrong
This is an observational study using existing data, so the AI models may not perform as well in real-world settings. Results are exploratory and not yet validated for clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CISMed, Centre for Medical Sciences

    RECRUITING

    Trento, 38122, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.